| Title: |
Effect of the added plasma rinseback on residual cell types in plateletpheresis leukoreduction systems. |
| Authors: |
Kelly, Kathleen, Finlon, Jeff, Fulciniti, Stefan, Lee, Deborah, Jones, Micaela, Marschner, Susanne |
| Source: |
Transfusion; Jan2025, Vol. 65 Issue 1, p202-210, 9p |
| Subject Terms: |
LEUKOCYTES, BLOOD platelets, HEMATOLOGY, LYMPHOPENIA, LYMPHOCYTES, HEMAPHERESIS |
| Abstract: |
Background: Platelets collected by the Trima Accel apheresis device (Terumo BCT) are automatically leukoreduced through a leukoreduction system (LRS) where WBCs are trapped in a conical‐shaped LRS chamber. The content has been used as a valuable source of mononuclear cells for research purposes. In frequent, long‐term platelet apheresis donors, lymphopenia has been associated with the use of LRS chambers, and implementation of plasma rinseback at the end of the procedure has been shown to mitigate the depletion of lymphocytes. In this report, the cellular content of the LRS chamber and remaining disposable was characterized with and without plasma rinseback. Study Design and Methods: Trima disposable sets were obtained from apheresis platelet collections in 100% plasma or 35% plasma/65% PAS with or without plasma rinseback at the end of the collections. Cellular content was drained from the LRS chamber and the disposable and was characterized using a hematology analyzer and flow cytometer to establish total cell counts and proportions of RBC, platelet, and WBC subpopulations. Results: LRS chambers contained approximately 109 WBCs, with the majority being lymphocytes and monocytes. The addition of plasma rinseback significantly decreased the number of WBCs remaining in the disposable, thereby increasing the number of WBCs returned to the donor. However, rinseback did not impact the WBC content of the LRS chamber itself. Conclusions: Blood Centers using the Trima Accel instrument may reduce lymphopenia in regular platelet donors by implementing plasma rinseback, while ensuring the cellular content of the LRS chamber intended for research purposes remains unaffected. [ABSTRACT FROM AUTHOR] |
|
Copyright of Transfusion is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |
